Short answer: no, it does not appear on standard workplace testing
10.1016/j.cyto.2019.154819 5
GLP-1 Medications and Thyroid Medication Interactions Semaglutide and tirzepatide slow gastric emptyingthe rate at which food leaves the stomach
Appetite reduction also serves to help you feel fuller longer and resist unhealthy cravings, so you end up consuming fewer calories and making healthier dietary choices
Similarly, semaglutide for weight loss is titrated to a target subcutaneous dose of 2.4 mg/week, while its oral formulation -approved for T2DM management- is administered at 314 mg/day [39]
While compounded drugs can be beneficial in some cases, they generally pose a higher risk than FDA-approved drugs because they do not undergo the same rigorous premarket review for safety, effectiveness, or quality